期刊文献+

二代测序技术在结核分枝杆菌研究中的应用进展 被引量:12

Current applications of next-generation sequencing technology in Mycobacterium tuberculosis research
下载PDF
导出
摘要 结核病是由结核分枝杆菌引起的全球第二大传染病。二代测序技术为从基因组水平研究结核分枝杆菌提供了重要的研究方法。本文从结核病流行病学、结核分枝杆菌耐药和进化及相关生物信息学等方面,介绍二代测序技术在结核分枝杆菌研究中的应用进展。 Tuberculosis caused by Mycobacterium tuberculosis (M. tuberculosis) is the second important infectious disease in the world, and next-generation sequencing technology provides an effective research method to study the genome of M. tuberculosis. The current applications of next-generation sequencing technology in the study of M. tuberculosis from the aspects of epidemiology, drug resistance, evolution and related bioinformatics are reviewed.
出处 《微生物与感染》 2015年第1期54-60,共7页 Journal of Microbes and Infections
关键词 结核分枝杆菌 二代测序 基因组 Mycobacterium tuberculosis Next-generation sequencing Genome
  • 引文网络
  • 相关文献

参考文献55

  • 1Eurosurveillance Editorial Team. WHO publishes global tuberculosis report 2013 [J]. Euro Surveill, 2013, 18 (43) :20615.
  • 2Hartkoorn RC, Sala C, Uplekar S, Busso P, Rougemont J, Cole ST. Genome-wide definition of the SigF regulon in Mycobacterium tuberculosis [J]. J Bacteriol, 2012, 194(8): 2001-2009.
  • 3Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence [J]. Nature, 1998, 393(6685) : 537-544.
  • 4Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs WR Jr, Venter JC, Fraser CM. Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains [J]. J Bacterioh 2002, 184(19): 5479-5490.
  • 5Niemann S, Koser CU, Gagneux S, Plinke C, Homolka S, Bignell H, Carter RJ, Cheetham RK, Cox A, Gormley NA, Kokko-Gonzales P, Murray I_J, Rigatti R, Smith VP, Arends FP, Cox HS, Smith G, Archer JA. Genomic diversity among drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis with identical DNA fingerprints [J]. PLoS One, 2009, 4(10): e7407.
  • 6Gardy JL, Johnston JC, Ho Sui SJ, Cook VJ, Shah L, Brodkin E, Rempel S, Moore R, Zhao Y, Holt R, Varhol R, Birol I, Lem M, Sharma MK, Elwood K, Jones SJ, Brinkman FS, Brunham RC, Tang P. Whole-genome sequencing and social-network analysis of a tuberculosis outbreak [J]. New Engl J Med, 2011, 364(8): 730-739.
  • 7MacLean D, Jones JD, Studholme DJ. Application of 'next- generation' sequencing technologies to microbial genetics [J]. Nat Rev Microbiol, 2009, 7(4): 287-296.
  • 8Walker TM, Monk P, Smith EG, Peto TE. Contact investigations for outbreaks of Mycobacterium tuberculosis: advances through whole genome sequencing [ J ]. Clin Microbiol Infect, 2013, 19(9): 796-802.
  • 9Medini D, Serruto D, Parkhill J, Relman DA, Donati C, Moxon R, Falkow S, Rappuoli R. Microbiology in the post- genomic era [J]. Nat Rev Microbiol, 2008, 6(6) : 419-430.
  • 10Coll F, Mallard K, Preston MD, Bentley S, Parkhill J, McNerney R, Martin N, Clark TG. SpolPred, rapid and accurate prediction of Mycobacterium tuberculosis spoligotypes from short genomic sequences [J]. Bioinformatics, 2012, 28(22) : 2991-2993.

同被引文献163

  • 1孙冰梅,车志宏.结核分枝杆菌耐药的分子机制及耐药基因检测方法的研究进展[J].山西医药杂志,2005,34(4):301-303. 被引量:13
  • 2张国龙,杜长梅,苍泽卓也,池田雄史,王伟,石瑞如.中日合作对河南省结核菌二线药物耐药监测研究[J].医药论坛杂志,2005,26(19):14-16. 被引量:15
  • 3姜英,彭俊平,杨帆,余黎,王玉琳,金奇.结核分枝杆菌耐吡嗪酰胺分子机制研究[J].微生物学免疫学进展,2007,35(1):5-9. 被引量:12
  • 4World Health Organization. Global tuberculosis report 2015. Geneva: World Health Organization, 2015.
  • 5Van Rie A, Enarson D. XDR tuberculosis: an indicator of public-health negligence. Lancet, 2006, 368(9547): 1554- 1556.
  • 6Iseman MD. Evolution of drug-resistant tuberculosis: A tale of two species. Proc Natl Acad Sci USA, 1994, 91(7): 2428-2429.
  • 7Zhao YL, Xu SF, Wang LX, Chin DP, Wang SF, Jiang GL, Xia H, Zhou Y, Li Q, Ou XC, Pang Y, Song Y, Zhao B, Zhang HT, He GX, Guo J, Wang Y. National survey of drug-resistant tuberculosis in China. N Engl J Med, 2012, 366(23): 2161-2170.
  • 8Migliori GB, De Iaco G, Besozzi G, Centis R, Cirillo DM. First tuberculosis cases in Italy resistant to all tested drugs Euro Surveill, 2007, 12(5): E070517.
  • 9Klopper M, Warren RM, Hayes C, van Pittius NCG, Streicher EM, Miiller B, Sirgel FA, Chabula-Nxiweni M, Hoosain E, Coetzee G, van Helden PD, Victor TC, Trollip AE Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa. Emerg Infect Dis 2013, 19(3): 449-455.
  • 10Udwadia ZF, Amale RA, Ajbani KK, Rodrigues C. Totally drug-resistant tuberculosis in India. Clin Infect Dis, 2012, 54(4): 579-581.

引证文献12

二级引证文献26

;
使用帮助 返回顶部